相关实验视频

Updated: Jul 13, 2025

Repression of Multiple Myeloma Cell Growth In Vivo by Single-wall Carbon Nanotube SWCNT-delivered MALAT1 Antisense Oligos

Repression of Multiple Myeloma Cell Growth In Vivo by Single-wall Carbon Nanotube SWCNT-delivered MALAT1 Antisense Oligos

Published on: December 13, 2018

埃尔雷克斯菲奥TM (elranatamab-bcmm):在多发性骨髓瘤治疗中的游戏改变者

Taruba Rais¹, Afsheen Khan¹, Rumaisa Riaz¹

¹Department of Internal Medicine, Dow University of Health Sciences, Karachi, Pakistan.

|October 16, 2023

概括

埃尔拉纳塔马巴-bcmm (ELREXFIO) 是一种针对复发性或耐火性多发性髓瘤的新疗法. 这种双特异性抗体向BCMA和CD3,激活T细胞以有效地对抗癌细胞.

科学领域:

血液学血液学血液学
免疫学免疫学免疫学
在瘤学瘤学.

背景情况:

多发性骨髓瘤是一种血细胞恶性瘤,具有不受控制的骨髓增殖.
骨髓微环境的相互作用在多发性骨髓瘤的进展和骨质溶解中至关重要.
向瘤微环境在抑制骨髓瘤生长方面显示出有前途.

研究的目的:

引入elranatamab-bcmm (ELREXFIO),一种用于多发性骨髓瘤的新疗法.
要突出ELREXFIO作为两种特异性抗体的作用机制.
讨论ELREXFIO在复发/耐药多发性髓瘤患者的临床疗效和耐受性.

主要方法:

埃拉拉纳塔马布-bcmm是一种针对CD3和B细胞成熟抗原 (BCMA) 的双特异性抗体.
它激活细胞毒性T淋巴细胞,诱导BCMA表达性髓瘤细胞中的细胞死亡.
包括MagnetisMM-3在内的临床试验评估了其安全性和有效性.

主要成果:

在临床试验中,Elranatamab-bcmm在临床试验中显示出显著的反应率.
在接受ELREXFIO治疗的患者中观察到长期耐受性.
该药物在治疗复发性和耐火性多发性骨髓瘤方面表现有前途.

结论:

埃拉拉纳塔马巴-bcmm (ELREXFIO) 是FDA批准的治疗方法,为多发性骨髓瘤患者提供了新的希望.
用双特异性抗体向BCMA是对抗多发性骨髓瘤的有效策略.
像ELREXFIO这样的创新疗法正在改善这种具有挑战性的血液恶性瘤的结果.

关键词:

多发性骨髓瘤是一种多发性骨髓瘤.两种特定抗体的抗体.埃拉纳塔马巴-bcmmmm 的意思免疫疗法免疫疗法骨髓瘤的进展情况

更多相关视频

Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs

Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs

Published on: May 15, 2019

Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography

Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography

Published on: February 17, 2022

相关概念视频

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...